These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16802010)

  • 21. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver fibrosis: pathophysiology, diagnosis and treatment].
    Pár A; Pár G
    Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining non-invasive methods for assessment of liver fibrosis.
    Bourlière M; Pénaranda G; Adhoute X; Oules V; Castellani P
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):73-9. PubMed ID: 18973849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy?
    Mardini H; Record C
    Ann Clin Biochem; 2005 Nov; 42(Pt 6):441-7. PubMed ID: 16259794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological markers of fibrosis].
    Fernández-Varo G
    Gastroenterol Hepatol; 2012 Dec; 35 Suppl 2():10-6. PubMed ID: 23298654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of FIBROSpect II with histologic and morphometric evaluation of liver fibrosis in chronic hepatitis C.
    Patel K; Nelson DR; Rockey DC; Afdhal NH; Smith KM; Oh E; Hettinger K; Vallée M; Dev A; Smith-Riggs M; McHutchison JG
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):242-7. PubMed ID: 18187364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinical and histopathologic perspective on evolving noninvasive and invasive alternatives for liver biopsy.
    Van Leeuwen DJ; Balabaud C; Crawford JM; Bioulac-Sage P; Dhillon AP
    Clin Gastroenterol Hepatol; 2008 May; 6(5):491-6. PubMed ID: 18455694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and quantitation of fibrosis.
    Manning DS; Afdhal NH
    Gastroenterology; 2008 May; 134(6):1670-81. PubMed ID: 18471546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Other non-invasive markers of liver fibrosis.
    Leroy V
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):52-7. PubMed ID: 18973846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
    Koivisto H; Hietala J; Niemelä O
    Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
    Moreno S; García-Samaniego J; Moreno A; Ortega E; Pineda JA; del Romero J; Tural C; von Wichmann MA; Berenguer J; Castro A; Espacio R
    J Viral Hepat; 2009 Apr; 16(4):249-58. PubMed ID: 19215579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum markers of liver fibrosis].
    Schuppan D; Jax C; Hahn EG
    Dtsch Med Wochenschr; 1999 Oct; 124(41):1213-8. PubMed ID: 10572522
    [No Abstract]   [Full Text] [Related]  

  • 39. [Assessment of hepatic injury in patients with chronic viral hepatitis].
    Hrstić I; Ostojić R; Vucelić B
    Acta Med Croatica; 2009 Dec; 63(5):371-5. PubMed ID: 20198894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Reversibility of advanced liver fibrosis--therapeutic possibility and biochemical monitoring of the disease].
    Lebensztejn DM
    Przegl Epidemiol; 2005; 59(2):535-40. PubMed ID: 16190564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.